Amplia Therapeutics Limited announced that Mr. Tim Luscombe will replace Mr. Hamish George as Chief Financial Officer (CFO) of the Company. Mr. Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | +3.33% | +1.64% | -22.50% |
1st Jan change | Capi. | |
---|---|---|
-22.50% | 11.44M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Limited Announces Chief Financial Officer Changes